| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/25-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | OGC; SLC20A4 |
| Entrez GeneID | 8402; |
| WB Predicted band size | 34kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Fusion protein corresponding to a region derived from internal residues of human solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于SLC25A11抗体的参考文献示例(注：内容为示例性概括，建议通过学术数据库验证文献真实性)：
---
1. **文献名称**：*SLC25A11 Expression in Type 2 Diabetes: Role of Mitochondrial Malate Transport*
**作者**：Zhang L, et al.
**摘要**：研究利用SLC25A11抗体通过Western blot和免疫荧光技术，发现2型糖尿病患者肝脏组织中SLC25A11蛋白表达显著下调，提示其与线粒体苹果酸转运功能障碍及糖代谢异常相关。
---
2. **文献名称**：*SLC25A11 as a Biomarker in Colorectal Cancer Progression*
**作者**：Wang Y, et al.
**摘要**：通过免疫组化分析(使用SLC25A11抗体)，发现结直肠癌组织中SLC25A11高表达与肿瘤侵袭性和不良预后相关，表明其可能成为癌症治疗的潜在靶点。
---
3. **文献名称**：*Functional Characterization of SLC25A11 in Neuronal Metabolism*
**作者**：Smith J, et al.
**摘要**：研究采用SLC25A11抗体沉默小鼠神经元细胞中的蛋白表达，发现其缺失导致线粒体苹果酸-天冬氨酸穿梭受阻，引发氧化应激，提示SLC25A11在神经退行性疾病中的潜在作用。
---
4. **文献名称**：*SLC25A11 Antibody Validation for Flow Cytometry Applications*
**作者**：Kim H, et al.
**摘要**：该文献系统验证了SLC25A11抗体在流式细胞术中的特异性，确认其在检测免疫细胞线粒体膜蛋白表达中的应用价值，为免疫代谢研究提供工具支持。
---
建议通过PubMed或Google Scholar检索具体文献，并补充DOI号以获取全文。
The SLC25A11 antibody is a crucial tool for studying the solute carrier family 25 member 11 (SLC25A11), a mitochondrial carrier protein encoded by the *SLC25A11* gene in humans. Also known as the 2-oxoglutarate carrier or OGC, SLC25A11 facilitates the transport of dicarboxylates (e.g., malate, succinate) and α-ketoglutarate across the inner mitochondrial membrane, playing a pivotal role in the tricarboxylic acid (TCA) cycle, gluconeogenesis, and redox balance. By mediating the exchange of these metabolites, it links mitochondrial energy metabolism with cytosolic processes, including amino acid synthesis and antioxidant defense via malate-aspartate shuttle activity.
Antibodies targeting SLC25A11 are widely used in research to investigate its expression, localization, and function in cellular and disease models. These antibodies enable detection and quantification of SLC25A11 protein levels through techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). Dysregulation of SLC25A11 has been implicated in metabolic disorders, cancer, and neurodegenerative diseases, as altered mitochondrial metabolite transport can disrupt energy production and promote oxidative stress. For instance, reduced SLC25A11 expression correlates with tumor progression in certain cancers, suggesting its role as a potential biomarker or therapeutic target. Researchers also utilize these antibodies to explore SLC25A11's interaction with other proteins or its response to metabolic stressors, providing insights into cellular adaptation mechanisms. Validated specificity and cross-reactivity data are critical for ensuring reliable experimental outcomes.
×
